RC48-ADC monotherapy or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low and null expression: a multicenter, real-world, retr... by Daining Wang, Manming Cao, Yijun Zhang, Liangkuan Bi, Meiting Chen, Mengqian Ni, Qiufan Zheng, Kai Yao, Zhuowei Liu, Xia Yang, Yanxia Shi, Zhiming Wu, Xin An

Get full text